A single line often inverts meaning once you see what it
answers, so neighbouring messages are always shown.
-
Oct. 1, 2022 - We had a 1 hour meeting today with all the relevant members of HHS (CDC, NIH, BARDA, ASPR, etc. ) led by deputy secretary Andrea Palm to work out the departmental approach towards the Ebola outbreak in Uganda. The NIH's (NIAID) major role will be to provide 100 doses of the Sudan specific ebola vaccine from our VRCfor Uganda. In order to go through the proper diplomatic channels, Dr. Tedros (DG of WHO) wrote me an official letter requesting that I send our hundred doses to Uganda (see below): Director_National Institute of Allergy a
-
Oct. 2, 2022 We had multiple zooms today (with HHS folks) that will culminate with a briefing of secretary Becerra on the evolving situation of Ebola in Uganda. I brought up in the premating the consistent difficulties that we have with WHO who always want to actually design the protocols and then have organizations like NIH or CDC be the implementers of their protocols. This arrogance lies fundamentally with Anna Maria Restropo who has clashed frequently with Cliff Lane in prior Ebola situations dating back to 2014. We shall see how all of this plays out. Currently, there are 30 confirmed cases of Ebola in Uganda and more than 20 probable cases. In the zoom meetings we discussed all of the things that we discussed in the past when ebola struck West Africa and DRC. This has to do with the availability of testing, with the issue of travel into the country of people who might be infected with ebola, as well as our role in supplying vaccines testing and therapies in the form of monoclonal antibodies and other drugs to the Ugandans. More to come. Becerra backs my concern about the WHO trying to dictate the design of clinical trials. I referred to Anna Maria Restropo without mentioning her name. Becerra gets it.
-
Oct. 4, 2022 Starting to get significant uptick in cases in the UK. This is troublesome since we usually follow them by about four to five weeks.
-
Oct. 5, 2022 An example of the White House over ruling CDC. Rochelle and the CDC do not want to require entry screening of people coming in from Uganda in the context of ebola; however, the White House is very hyper about covering all the bases and on demanding a modified form of entry screening even though Uganda is requiring exit screening. PRESS: CBS "The Late Show with Stephen Colbert
-
2022-10-06 00:00
Anthony S. Fauci
Oct. 6, 2022 USA i i I l i I I I j l I I 1.4} 1.2} 0.8 0.6L Loa cog gig Le d9g bt dg O14 esd Lb Lag 9S'Vd LSsov¢ gSvd 6eS Va leeSva esva olsov¢g Ol lS va Svd 9VVE cvvda Lyvd yvd 6eVa SLeVva cv" @ BA5.1.2 @BA5.2.9 @ BF.21 @BA5.1.5 @BA55 @BF.5 @ BA4.1 @ BA.2.12.1 @ BA4.2 @ BA2 wuOdd = iow ww @®ee#eese ®@ taaad @®eee7? se = @®eee?2 °® N oO © nm Ww @ BA.5.1.10 @ BA5.2.22 @ BF.10 @ BA.5.1.18 @ BA5.2.6 @ BF.11 @ BA.2.9 @ BA4 Oc Sep Aug Jul Yesterday I went up to New York City to appear on The Late Show with Stephen Colbert. It was hilarious and the theme was to give people their booster shot. As part of the scripted show he asked me if I was going to get my booster and I said I'm due for it and he said well let's go get it. We got up walked out of the studio went to the Duane Reade pharmacy and got the shot. The response to the show has been phenomenal!! Many new variants hovering around. From Trevor Bedford: PRESS: NJ PBS "Chat Box" with David Cruz; News Nation with Chris Cuomo;
-
Oct 6, 2022 Washington Post:
-
Oct. 7, 2022 Note the growth advantage that BQ.1.1. has over BA.5. We definitely need to watch out for these new Omicron sublineage variants as we approach late Fall/early Winter : Growth rate advantage relative to BA.5.2 (% per day) GROWTH RATE ADVANTAGE OF SARS-CoV2 VARIANTS based on multinomial spline fit variant ~ ns(date, df=2)+ns(date, df=2):continent+country, GISAID & COG-UK data, using data from countries with >=5 BQ.1, BQ.1.1, BJ.1, XBB, BA.2.3.20 or BA.2.75.2 (Australia, Austria, Bangladesh, Belgium, Brunei, Canada, Denmark, France, Germany, India Ireland, Israel, Italy, Japan, Netherlands, New Zealand, Nigeria, Portugal Singapore, Slovakia, South Korea, Spain, Sweden, Switzerland, Thailand, United Kingdom, USA) 10I : ae _ e a ae gh > ny & © Vy a ye © ce & ns = se & s oe s rs & e se i We are doing very poorly compared to other countries in boosting out population: COVID-19 vaccine boosters administered per 100 people Our World Total number of vaccine booster doses administered, divided by the total population of the country. Booster doses are doses administered beyond those prescribed by the original vaccination protocol. woe @Addcountry in Data Japan Belgium Italy Germany Portugal ~ Canada France United Kingdom High income United States O; SEs T T i
-
Oct. 8, 2022 United States • Total Cases: 96,363,451 7-Day average: 43,693 (-8.4%) • Total Deaths: 1,056,029 7-Day average: 324 (-13.1%) • Total new hospital admissions: 5,376,728 7-Day average 3,376 (-7.8%) Worldwide [Source: WHO] - most recent day • Total Cases: 616,951,418 (466,669 new) • Total Deaths: 6,530,281 (1,543 new)
-
Oct. 9, 2022 PRESS: CNN with Pamela Brown;